Research Terms
Psychology Abnormal Psychology Cognition Intelligence Memory
Keywords
Adhd Behavioral Treatment Clinical Psychology Digital Health Statistics Working Memory
Industries
Biotech Health Care Medical Devices
Helping digital health products work clinically and scale commercially by bridging behavioral science, quality, and medical affairs in regulated environments.
I am a behavioral scientist and psychologist working at the intersection of digital health, digital therapeutics (DTx), and quality and medical affairs. My work focuses on translating behavioral science into evidence-based, compliant digital health solutions that can be developed, validated, and scaled within regulated healthcare settings.
I work cross-functionally with design, product, regulatory, quality, medical, and commercial teams, and collaborate closely with external partners, academic institutions, and vendors to ensure digital health solutions are practical, clinically meaningful and deliver real-world health outcomes for patients.
My experience spans academia, venture-backed startups (from seed stage through Series D), and pharma organizations. Across these environments, I have contributed to clinical evidence strategies, supported regulatory pathways (including FDA and CE marking), and partnered with quality, regulatory, clinical, and commercial teams to ensure digital products meet scientific, medical, and governance expectations.
I have worked on evidence generation and scientific strategy to support product development, launch, and post-market activities, including engagement with internal and external stakeholders. I have also worked on AI-enabled wellness solutions, with a focus on responsible and compliant use of generative AI to augment behavioral interventions and coaching workflows. I am particularly focused on ensuring that digital health and DTx products are not only innovative, but clinically meaningful, scientifically credible, and aligned with real-world clinical practice to maximize impact for users.
Little, K.*, Raiker, J., Coxe, S., Campez, M., Jusko, M., Smith, J., Gnagy, E., Greiner, A., Villodas, M., Coles, E., & Pelham, W. (online early). A Preliminary Evaluation of the Utility of Sluggish Cognitive Tempo Symptoms in Predicting Behavioral Treatment Response in Children with Behavioral Difficulties. Psychological Reports.
Smith, J.N.*, Raiker, J.S., Fosco, W.D., Jusko, M.L., Campez, M., Little, K., Mattfeld, A., Espinal, K., Sanchez, G., Merrill, B., Musser, E.D., Gnagy, E., Greiner, A., Coles, E., & Pelham, W.E. (2020). Executive Functioning and Activity in Children: a Multimethod Examination of Working Memory, Inhibition, and Hyperactivity. Journal of Abnormal Child Psychology, 48, 1143-1153.
Campez, M.*, Raiker, J.S., Sarver, D.E., Friedman, L.M., Orban, S.A., & Rapport, M.D. (2020). Working memory capacity and ADHD symptoms: Examining the heterogeneity of working memory functioning using latent profile analysis. Journal of Psychopathology & Behavioral Assessment, 42, 450-463.
Raiker, J.S., Friedman, L.M., Orban, S.A., Kofler, M.J., Sarver, D.E., & Rapport, M.D. (2019). Phonological working memory deficits in ADHD revisited: The role of lower-level information processing deficits in impaired working memory performance. Journal of Attention Disorders, 23, 570-583.
Musser, E., & Raiker, J.S. (2019). Attention-deficit/hyperactivity disorder: An integrated developmental psychopathology and research domain criteria (RDoC) approach. Comprehensive Psychiatry, 90, 65-72.
Raiker, J.S., Freeman, A.J., Perez-Algorta, G., Frazier, T.W., Findling, R.L., & Youngstrom, E.A. (2017). Accuracy of Achenbach Scales in the Screening of ADHD in a Community Mental Health Clinic. Journal of the American Academy of Child and Adolescent Psychiatry, 56, 401-409.
Raiker, J.S., Greening, L., Stoppelbein, L., Becker, S.P., Fite, P.J., & Luebee, A.M. (2015). Mediating Effect of Psychopathy on the Risk of Social Problems Among Children with ADHD Versus Sluggish Cognitive Tempo Symptoms. Child Psychiatry & Human Development, 46, 523-532.
Helping digital health products work clinically and scale commercially by bridging behavioral science, quality, and medical affairs in regulated environments.
I am a behavioral scientist and psychologist working at the intersection of digital health, digital therapeutics (DTx), and quality and medical affairs. My work focuses on translating behavioral science into evidence-based, compliant digital health solutions that can be developed, validated, and scaled within regulated healthcare settings.
I work cross-functionally with design, product, regulatory, quality, medical, and commercial teams, and collaborate closely with external partners, academic institutions, and vendors to ensure digital health solutions are practical, clinically meaningful and deliver real-world health outcomes for patients.
My experience spans academia, venture-backed startups (from seed stage through Series D), and pharma organizations. Across these environments, I have contributed to clinical evidence strategies, supported regulatory pathways (including FDA and CE marking), and partnered with quality, regulatory, clinical, and commercial teams to ensure digital products meet scientific, medical, and governance expectations.
I have worked on evidence generation and scientific strategy to support product development, launch, and post-market activities, including engagement with internal and external stakeholders. I have also worked on AI-enabled wellness solutions, with a focus on responsible and compliant use of generative AI to augment behavioral interventions and coaching workflows. I am particularly focused on ensuring that digital health and DTx products are not only innovative, but clinically meaningful, scientifically credible, and aligned with real-world clinical practice to maximize impact for users.
Speaker Topics
Abnormal psychology Child Development Digital Digital Health Digital Parenting
Target Audiences
Fee Range
